Press Release

CardioComm Solutions to Launch HeartCheck™ Technology for Atrial Fibrillation Screening and Stroke Prevention Trial in Canadian Rexall Pharmacies

by

CIHR, Industry and Heart and Stroke funded study will start with in-pharmacy screening in October 2014 Toronto, Canada – CardioComm Solutions, Inc. (TSX-V:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced it has completed its technology placement for the Canadian Stroke Prevention Intervention Network … Read more

CardioComm Solutions Completes Joint Venture Licensing and Service Agreement with USA based Vigilance, Inc. for Entry into the USA Based Outpatient Cardiac Monitoring Markets

by

Joint Venture will provide CardioComm Solutions with an equity position in Vigilance and recurrent licensing revenues TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions has executed a binding Letter of Intent with Vigilance, Inc. to develop and co-market … Read more

Pharmacy.ca To Provide Internet-Based Pharmacy Sales Of Cardiocomm Solutions’ Heartcheck™ Pen ECG Device

by

Web-based site provides access to the HeartCheck™ PEN by Canadians who are without easy access to pharmacies TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced a distribution agreement with Toronto-based PHARMACY.CA, for internet-based sales of the … Read more

CardioComm Solutions, Inc. Completing Corporate Restructuring to Focus on Sales and Marketing

by

Company Shifts Focus from R&D to Increased Resourcing of ECG Software Sales and Customer Support TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), today announced operations and sales team changes intended to drive inside-sales through upgrading the Company’s medical software customers to the new Windows 7 compatible Global ECG Management … Read more

GEMS™ WIN For Windows 7 Software Upgrade Launch Yields Early Wins For Cardiocomm Solutions, Inc.

by

Active sales and marketing efforts of GEMS™ WIN as a Windows 7 compatible ECG management software nets new license agreements from a wide array of customers TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that sales of its new Global ECG Management System release (GEMS™  WIN), a Windows … Read more

UK-based Arrhythmia Alliance to Highlight CardioComm Solutions’ HeartCheckTM PEN ECG Device on its Website

by

Web-Presence will introduce the HeartCheck™ device to a global network of patients and affiliate organizations TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced an agency agreement with Arrhythmia Alliance based out of the United Kingdom.  The … Read more

CARDIOCOMM SOLUTIONS IS LISTED BY THE FAA CIVIL AEROSPACE MEDICAL INSTITUTE AS AN ECG CLOUD SERVICES PROVIDER FOR USE BY AIR MEDICAL EXAMINERS

by

ECG Modernization Project Links CardioComm Solutions to the FAA Aviation Medical Examiner (AME) Community TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today confirmed that it has been listed as a cloud services provider under the launch of the Federal Aviation Administration (“FAA”) Civil Aerospace Medical Institute ECG Modernization project. … Read more

CARDIOCOMM SOLUTIONS AND THE HEART AND STROKE FOUNDATION OF CANADA PARTNER TO PERFORM COMMUNITY BASED ECG SCREENING IN SUPPORT OF THE “SCREEN FOR ATRIAL FIBRILLATION EVERYWHERE (SAFE)” STUDY.

by

Screening efforts designed to increase awareness and provide education of the warning signs and implications of Atrial Fibrillation as a risk factor for stroke. TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) CardioComm Solutions and the Heart and Stroke Foundation are working together to implement the Company’s SMART Monitoring based … Read more

CardioComm Solutions Announces Issuance of Stock Options and Shares

by

CardioComm Solutions to begin immediate rollout of GEMS™ for Windows 7 remote ECG analysis, data management software to extensive base of current US health care providers and customers. TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has granted an aggregate of 500,060 incentive stock options. 250,060 options … Read more

CardioComm Solutions’ HeartCheck™ ECG PEN and GEMS™ Home Receive China Food and Drug Administration Clearance

by

Clearance opens the way for HeartCheck™ Device Sales and SMART Monitoring ECG Services in China TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, confirms that China’s Food and Drug Administration (“CFDA”) has cleared the HeartCheck™ PEN ECG device … Read more